TMS Therapy Guide: Benefits, Risks, Candidate Assessment & Treatment
Transcranial magnetic stimulation (TMS) is a noninvasive brain-stimulation treatment most commonly used for depression that has not improved enough with medication, psychotherapy, or other standard treatments. TMS uses precisely targeted magnetic pulses to influence brain networks involved in mood regulation while the patient remains awake and without the need for general anesthesia. This comprehensive guide explains how TMS works, what treatment feels like, common treatment schedules, expected benefits, possible side effects, seizure and bipolar-spectrum considerations, and important safety factors. It also includes a detailed scoreable questionnaire designed to help patients organize their treatment history, symptoms, preferences, and practical considerations before discussing TMS with a psychiatrist or TMS specialist.
Transcranial Magnetic Stimulation • Psychoeducation • Candidacy Discussion • Treatment Planning
Complete Guide to TMS
An in-depth patient guide to transcranial magnetic stimulation, including how TMS works, what it treats, what treatment feels like, benefits and limitations, side effects, contraindication screening, treatment-course expectations, and a comprehensive scoreable questionnaire to help prepare for a TMS consultation.
Mark Zauss, BC-TMC, LMHC, LPC, CCMHC, NCC, ASDCS, CCTP, CCTP II, NATC, ADHD-CCSP, C-DBT, C-PD
This is an educational decision-support worksheet. It does not establish TMS eligibility, predict response, or replace evaluation by a psychiatrist or TMS physician.
This is an educational decision-support worksheet. It does not establish TMS eligibility, predict response, or replace evaluation by a psychiatrist or TMS physician.
What is TMS?
Transcranial magnetic stimulation (TMS) is a noninvasive brain-stimulation treatment. A treatment coil placed against the scalp creates rapidly changing magnetic fields that induce small electrical currents in targeted brain tissue. The patient remains awake; standard TMS does not intentionally produce a seizure and does not normally require general anesthesia.
TMS is not one single protocol. Traditional repetitive TMS (rTMS), deep TMS, intermittent theta-burst stimulation (iTBS), and accelerated approaches vary in coil design, pulse pattern, treatment duration, and FDA-cleared indication. The treating clinic should tell the patient exactly which device and protocol are being recommended.
TMS uses repeated magnetic stimulation to influence targeted brain networks over a course of treatment.
What is TMS used for?
Major Depression
Its best-established psychiatric use is treatment-resistant major depression, particularly when medication and psychotherapy have not produced sufficient improvement or medications have been poorly tolerated.
Other Cleared Uses
Specific FDA-cleared devices/protocols are also used for conditions including OCD, migraine, smoking dependence, and certain depressive presentations. Clearance depends on the specific device and protocol.
Research / Off-Label Uses
TMS is being studied for many additional psychiatric and neurological conditions. An off-label or investigational use should be clearly identified as such rather than presented as broadly FDA-cleared.
What does a treatment course look like?
| Step | What usually happens |
|---|---|
| Evaluation | Diagnosis, prior treatments, bipolar screening, current medications, seizure risk, neurological history, implanted devices/metal, and treatment goals are reviewed. |
| Mapping / motor threshold | The treatment team determines stimulation intensity and target positioning using a motor-threshold procedure or another protocol-specific method. |
| Sessions | Traditional courses commonly involve frequent outpatient sessions over several weeks. Theta-burst and accelerated protocols can use different schedules. |
| Monitoring | Depression severity, anxiety, sleep, suicidality, side effects, and functional changes should be monitored throughout treatment. |
| After the acute course | Medication, psychotherapy, relapse prevention, tapering, maintenance TMS, or retreatment may be considered depending on response and recurrence. |
Benefits and limitations
Potential Advantages
- No routine general anesthesia
- Noninvasive
- Patient remains awake
- Generally low cognitive burden
- Many patients return to usual activities after treatment
- Can be helpful when medication has failed or is poorly tolerated
Important Limitations
- Requires repeated visits
- Does not help everyone
- Response may take several weeks
- Insurance requirements vary
- Some patients later need maintenance or retreatment
- It is generally less powerful and slower than ECT for severe urgent depression
Side effects and safety
Common side effects include scalp discomfort, headache, facial-muscle twitching, tingling, and lightheadedness. Serious side effects are uncommon but can include seizure, mood elevation/mania, or hearing injury if adequate hearing protection is not used. Clinicians should review seizure risk, bipolar history, medications that affect seizure threshold, implanted devices, and metal near the head before treatment.
Urgency matters: TMS may be an excellent outpatient option, but when depression is immediately life-threatening—such as severe suicidality, catatonia, or inability to eat/drink—a psychiatrist may recommend a faster-acting intervention such as ECT, ketamine/esketamine, hospitalization, or another acute strategy.
Patient information
TMS Candidate-Discussion Questionnaire
Rate each statement based on your current situation. Higher scores indicate a stronger discussion fit for a TMS consultation—not guaranteed eligibility or response.
0 = Not at all1 = A little2 = Moderately3 = Strongly4 = Very strongly
Safety & Differential Screening
These items are not included in the score. They flag issues that require direct psychiatrist/medical review.
Results
Complete the questionnaire and calculate your profile.
| Profile percentage | Meaning |
|---|---|
| 0–39% | Limited current fit based on answered items; standard-treatment optimization or practical barriers may need attention first. |
| 40–59% | Mixed profile; TMS may still be worth discussing, but several factors require clarification. |
| 60–79% | Strong discussion profile for a formal TMS consultation if safety screening is acceptable. |
| 80–100% | Very strong discussion profile, while still requiring diagnosis, medical safety review, and device/protocol-specific eligibility. |
Automated AI-Style Summary
This summary organizes the responses. It does not prescribe TMS, determine insurance coverage, or replace a psychiatrist's evaluation.
No summary generated yet.
Questions to ask a TMS clinic
Protocol
Which device and protocol are you recommending? Is it FDA-cleared for my diagnosis? Traditional rTMS, deep TMS, iTBS, or accelerated treatment?
Outcome Tracking
How will you measure improvement? What happens if I have partial response, no response, or symptom worsening?
Medication
Which medications should stay the same? Do any affect seizure threshold? How will bipolar activation be monitored?
Maintenance
Will I need a taper, maintenance sessions, medication changes, or retreatment if symptoms return?
Your questions for the treating psychiatrist
APA-style clinical resources
- American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Association Publishing.
- National Institute of Mental Health. (n.d.). Brain stimulation therapies. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies
- National Institute of Mental Health. (n.d.). Depression. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/publications/depression
- National Institute for Health and Care Excellence. (2022, updated). Depression in adults: Treatment and management (NICE Guideline NG222). https://www.nice.org.uk/guidance/ng222
- Mayo Clinic. (n.d.). Transcranial magnetic stimulation. https://www.mayoclinic.org/tests-procedures/transcranial-magnetic-stimulation/about/pac-20384625
- Perera, T., George, M. S., Grammer, G., Janicak, P. G., Pascual-Leone, A., & Wirecki, T. S. (2016). The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimulation, 9(3), 336–346. https://doi.org/10.1016/j.brs.2016.03.010
- McClintock, S. M., Reti, I. M., Carpenter, L. L., McDonald, W. M., Dubin, M., Taylor, S. F., Cook, I. A., O'Reardon, J., Husain, M. M., Wall, C., Krystal, A. D., Sampson, S. M., Morales, O., Nelson, B. G., Latoussakis, V., George, M. S., & Lisanby, S. H. (2018). Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. Journal of Clinical Psychiatry, 79(1). https://doi.org/10.4088/JCP.16cs10905